The University of Chicago Header Logo

Connection

Fuad Baroody to Antibodies, Monoclonal, Humanized

Back to Details
This is a "connection" page, showing publications Fuad Baroody has written about Antibodies, Monoclonal, Humanized.
Fuad Baroody
Connection Strength
0.093
Antibodies, Monoclonal, Humanized
  1. Should clinicians use omalizumab for the treatment of nasal polyps? J Allergy Clin Immunol. 2013 Jul; 132(1):247.
    View in: PubMed
    Score: 0.077
  2. A randomized, double-blind, placebo-controlled trial of anti-IgE for chronic rhinosinusitis. Rhinology. 2010 09; 48(3):318-24.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.